Header Logo

Connection

Gary Chmielewski to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Gary Chmielewski has written about Lung Neoplasms.
Gary Chmielewski
Connection Strength
1.263
Lung Neoplasms
  1. The safe transition from open to thoracoscopic lobectomy: a 5-year experience. Ann Thorac Surg. 2009 Jul; 88(1):216-25; discussion 225-6.
    View in: PubMed
    Score: 0.229
  2. Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
    View in: PubMed
    Score: 0.102
  3. Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection. Lung. 2016 08; 194(4):619-24.
    View in: PubMed
    Score: 0.092
  4. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):55-61.e1.
    View in: PubMed
    Score: 0.092
  5. Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response. J Thorac Oncol. 2015 Oct; 10(10):1475-80.
    View in: PubMed
    Score: 0.088
  6. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules. Ann Thorac Surg. 2015 Aug; 100(2):429-36.
    View in: PubMed
    Score: 0.087
  7. Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.
    View in: PubMed
    Score: 0.083
  8. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J Thorac Oncol. 2013 Jan; 8(1):31-6.
    View in: PubMed
    Score: 0.073
  9. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1.
    View in: PubMed
    Score: 0.072
  10. Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors. Radiother Oncol. 2011 Apr; 99(1):18-22.
    View in: PubMed
    Score: 0.065
  11. Rapid disease progression with delay in treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):466-72.
    View in: PubMed
    Score: 0.061
  12. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection. Lung Cancer. 2010 Jun; 68(3):398-402.
    View in: PubMed
    Score: 0.058
  13. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Oct 01; 69(2):334-41.
    View in: PubMed
    Score: 0.050
  14. Lysyl oxidase expression in bronchogenic carcinoma. Am J Surg. 2005 Mar; 189(3):297-301.
    View in: PubMed
    Score: 0.042
  15. Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens. Am J Clin Pathol. 2003 Nov; 120(5):720-4.
    View in: PubMed
    Score: 0.039
  16. Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. Ann Thorac Surg. 2021 08; 112(2):436-442.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.